Donna Sparta, MS

Director, Clinical Operations
Neurocrine Biosciences, Inc.

Poster(s):

• (60) Valbenazine improves the impacts and symptoms of tardive dyskinesia: results from the phase 4 kinect-pro study
  Wednesday, October 29, 2025